摘要
目的分析联合使用检测降钙素元和C-反应蛋白检测对COPD患者病程评估的价值。方法比较总体样本(139例Ⅰ组)、PCT与CRP均高于正常值(67例Ⅱ组)、单纯PCT升高(82例Ⅲ组)、单纯CPR高于正常值(108例Ⅳ组)住院时间差异。结果Ⅰ组与Ⅱ组、Ⅲ组、Ⅳ组患者住院时间均存在差异(P<0.05),Ⅱ组与Ⅲ组住院时间无差异性(P>0.05),Ⅱ组与Ⅳ组住院时间存在差异(P<0.05),Ⅲ组与Ⅳ组住院时间无差异性(P>0.05)。结论 PCT联合CRP检测对COPD患者病程评估有意义,单项检测评估方面PCT优于CRP。
Objective To analyze the value of combined use of ealcitonin and C-reactive protein testing in the evaluation of COPD patients' course of disease. Methods The overall sample (139 cases Ⅰ group), PCT and CRP were higher than the normal value (67 cases Ⅱ Group), simple PCT increase (82 cases Ⅲ group), simple CPR higher than normal (108 cases Ⅳ group) hospitalization time difference. Results There were differences between group Ⅰ and group Ⅱ, group Ⅲ and Ⅳ group hospitalization time (P〈0.05), group Ⅱ and group hospitalization time no difference (P〉0.05), group Ⅱ and group Ⅳ hospitalization time difference (P〈0.05), group Ⅲ and IV group, there was no difference in hospitalization time (P〉0.05). Conclusion PCT combined with CRP test is significant in evaluating the course of patients with COPD, and PCT is superior to CRP in single item assessment.
出处
《中国继续医学教育》
2017年第12期127-129,共3页
China Continuing Medical Education
关键词
降钙素元
C-反应蛋白
慢性阻塞性肺疾病
临床路径
calcitonin gene
C-reactive protein
chronic obstructive pulmonary disease
clinical pathway